Leukemia inhibitory factor receptor (LIFR) is detected as a novel suppressor gene of hepatocellular carcinoma using double-combination array

Cancer Letters

Volumn 289, Issue 2, 2010, Pages 170-177

  Okamura, Yukiyasu ^a   Nomoto, Shuji ^a   Kanda, Mitsuro ^a   Li, Qiyong ^a   Nishikawa, Yoko ^a   Sugimoto, Hiroyuki ^a   Kanazumi, Naohito ^a   Takeda, Shin ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Expression array; Hepatocellular carcinoma; Leukemia inhibitory factor receptor; Single nucleotide polymorphism array; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; LEUKEMIA INHIBITORY FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE DUPLICATION; GENE EXPRESSION; HETEROZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; LEUKEMIA INHIBITORY FACTOR RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 76849112321     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.08.013     Document Type: Article

References (23)

1. Parkin D.M. Global cancer statistics in the year 2000. Lancet Oncol. 2 (2001) 533-543
2. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31 (2002) 339-346
3. Hsu I.C., Metcalf R.A., Sun T., Welsh J.A., Wang N.J., and Harris C.C. Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350 (1991) 427-428
4. Zhang X., Xu H.J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S.X., Benedict W.F., and Sekiya T. Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 54 (1994) 4177-4182
5. Yamada T., de Souza A.T., Finkelstein S., and Jirtle R.L. Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis. Proc. Natl. Acad. Sci. USA 94 (1997) 10351-10355
6. Zhang X.K., Huang D.P., Qiu D.K., and Chiu J.F. The expression of c-myc and c-N-ras in human cirrhotic livers, hepatocellular carcinomas and liver tissue surrounding the tumors. Oncogene 5 (1990) 909-914
7. Nishida N., Fukuda Y., Komeda T., Kita R., Sando T., Furukawa M., Amenomori M., Shibagaki I., Nakao K., Ikenaga M., and Ishizaki K. Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res. 54 (1994) 3107-3110
8. Hsu H.C., Jeng Y.M., Mao T.L., Chu J.S., Lai P.L., and Peng S.Y. Beta-catenin mutations are associated with a subset of low-stage hepatocellular carcinoma negative for hepatitis B virus and with favorable prognosis. Am. J. Pathol. 157 (2000) 763-770
9. Boix L., Rosa J.L., Ventura F., Castells A., Bruix J., Rodes J., and Bartrons R. c-Met mRNA overexpression in human hepatocellular carcinoma. Hepatology 19 (1994) 88-91
10. Midorikawa Y., Ishikawa S., Iwanari H., Imamura T., Sakamoto H., Miyazono K., Kodama T., Makuuchi M., and Aburatani H. Glypican-3 overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling. Int. J. Cancer 103 (2003) 455-465
11. Ito H., Funahashi S., Yamauchi N., Shibahara J., Midorikawa Y., Kawai S., Kinoshita Y., Watanabe A., Hippo Y., Ohtomo T., Iwanari H., Nakajima A., Makuuchi M., Fukayama M., Hirata Y., Hamakubo T., Kodama T., Tsuchiya M., and Aburatani H. Identification of ROBO1 as a novel hepatocellular carcinoma antigen and a potential therapeutic and diagnostic target. Clin. Cancer Res. 12 (2006) 3257-3264
12. Chen Y., Guo Y., Ge X., Itoh H., Watanabe A., Fujiwara T., Kodama T., and Aburatani H. Elevated expression and potential roles of human Sp5, a member of Sp transcription factor family, in human cancers. Biochem. Biophys. Res. Commun. 340 (2006) 758-766
13. Lu Y.J., Yang J., Noel E., Skoulakis S., Chaplin T., Raghavan M., Purkis T., McIntyre A., Kudahetti S.C., Naase M., Berney D., Shipley J., Oliver R.T., and Young B.D. Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development. Cancer Res. 65 (2005) 9137-9141
14. Raghavan M., Lillington D.M., Skoulakis S., Debernardi S., Chaplin T., Foot N.J., Lister T.A., and Young B.D. Genome-wide single nucleotide polymorphism analysis reveals frequent partial uniparental disomy due to somatic recombination in acute myeloid leukemias. Cancer Res. 65 (2005) 375-378
15. Teh M.T., Blaydon D., Chaplin T., Foot N.J., Skoulakis S., Raghavan M., Harwood C.A., Proby C.M., Philpott M.P., Young B.D., and Kelsell D.P. Genomewide single nucleotide polymorphism microarray mapping in basal cell carcinomas unveils uniparental disomy as a key somatic event. Cancer Res. 65 (2005) 8597-8603
16. Kishimoto T., Taga T., and Akira S. Cytokine signal transduction. Cell 76 (1994) 252-262
17. de Iglesia N., Konopka G., Puram S.V., Chan J.A., Bachoo R.M., You M.J., Levy D.E., Depinho R.A., and Bonni A. Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Gene Dev. 22 (2008) 449-462
18. Schena M., Shalon D., Davis R.W., and Brown P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270 (1995) 467-470
19. Lau W.Y., Lai P.B., Leung M.F., Leung B.C., Wong N., Chen G., Leung T.W., and Liew C.T. Differential gene expression of hepatocellular carcinoma using cDNA microarray analysis. Oncol. Res. 12 (2002) 59-69
20. Wang D.G., Fan J.B., Siao C.J., Beruno A., Young P., Sapolsky R., Ghandour G., Perkins N., Winchester E., Spencer J., Kruglyak L., Stein L., Hsie L., Topaloglou T., Hubbell E., Robinson E., Mittmann M., Morris M.S., Shen N., Kiburn D., Rioux J., Nusbaum C., Rozen S., Hudson T.J., Lipshutz R., Chee M., and Lander E.S. Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280 (1998) 1077-1082
21. Derouet D., Rousseau F., Alfonsi F., Froger J., Hermann J., Barbier F., Perret D., Diveu C., Guillet C., Preisser L., Dumont A., Barbado M., Morel A., deLapeyrière O., Gascan H., and Chevalier S. Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor. Proc. Natl. Acad. Sci. USA 101 (2004) 4827-4832
22. Li J., Yen C., Liaw D., Podsypanina K., Bose S., Wang S.I., Puc J., Miliaresis C., Rodgers L., McCombie R., Bigner S.H., Giovanella B.C., Ittmann M., Tycko B., Hibshoosh H., Wigler M.H., and Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275 (1997) 1943-1947
23. Blanchard F., Tracy E., Smith J., Chattopadhyay S., Wang Y., Held W.A., and Baumann H. DNA methylation controls the responsiveness of hepatoma cells to leukemia inhibitory factor. Hepatology 38 (2003) 1516-1528